Healthcare
Inogen, Inc.(INGN)
Live Price
Offline$6.41
+0.63% today
1Y Change
-9.97%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $190.00M
- Revenue Growth
- +3.9%
- EPS Growth
- +44.1%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Inogen, Inc. (INGN) is a Healthcare stock with a market cap of $190.00M and listed on NASDAQ. The stock last traded around $6.41 and down 10.0% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +3.9%, EPS growth of +44.1%, a dividend yield of 0.0%. What stands out right now is revenue +3.9%, EPS +44.1%, free cash flow -93.2% with operating margin -8.7% and ROIC -12.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.6. Stock Foundry combines INGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.9% vs +7.6% peer median
Operating Margin
Below sector median
-8.7% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +3.9% and EPS at +44.1%, with operating margin around -8.7%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.6% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +1.1% | -4.2% | -11.3% |
2026 Feb 24, 2026 | +27.8% | +2.9% | +6.3% | +8.2% |
2025 Nov 5, 2025 | +9.1% | -4.9% | -4.1% | -5.4% |
Benchmark Edge
INGN vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
INGN
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
INGN Max Drawdown
-37.54%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for INGN and SPY.
Company Overview
Inogen, Inc.
NASDAQ Global Select
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
- Leadership
- Kevin R. Smith
- IPO Date
- Feb 14, 2014
- Employees
- 766
- Street Address
- 301 Coromar Drive
- Mailing
- Goleta, CA, 93117
- Region
- Goleta, CA, US
- Reporting Currency
- USD
- Investor Line
- 805 562 0500
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 0.6
- Price/Book
- 1.0
Growth
- Revenue
- +3.9%
- EPS
- +44.1%
- Free Cash Flow
- -93.2%
Profitability
- Gross Margin
- 47.6%
- Operating Margin
- -8.7%
- Net Margin
- -6.5%
- ROE
- -11.6%
- ROIC
- -12.3%
Balance Sheet
- Debt/Equity
- 0.09
- Current Ratio
- 3.12
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.